Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	9.79	3.94	1.54	1.63	1.62	2.23
Short-Term Investments	1.25	1.28	4.93	4.47	0.53	1.84
Accounts Receivable	0.29	0.19	1.54	0.54	0.44	0.23
Other Receivables	2.88	2.19	4.53	8.17	13.12	3.91
Property, Plant & Equipment	0.34	0.39	0.14	0.29	0.16	0.37
Other Intangible Assets	0.08	0.08	0.08	0.08	0.08	0.08
Other Current Assets	0.03	0.71	0.6	0.58	0.07	0.06
Long-Term Deferred Tax Assets	0.48	0.4	0.27	0.04	0.04	0.05
Other Long-Term Assets	0.06	0.06	0.03	0.03	0.03	0.03
Total Assets	15.21	9.23	13.65	15.83	16.07	8.8
Accounts Payable	1.36	1.34	5.23	4.51	0.99	1.64
Accrued Expenses	0.49	0.42	0.35	0.68	0.67	0.02
Current Portion of Leases	0.15	0.15	0.14	0.16	0.15	0.19
Other Current Liabilities	-	-	-	-	-	0.1
Long-Term Leases	0.09	0.13	-	0.14	-	0.14
Total Liabilities	2.09	2.13	5.88	5.56	2.55	2.28
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	14.96	8.13	8.08	9.81	9.81	5.55
Retained Earnings	-1.84	-1.02	-0.31	0.46	3.72	0.97
Shareholders' Equity	13.12	7.11	7.78	10.27	13.53	6.52
Total Liabilities & Equity	15.21	9.23	13.65	15.83	16.07	8.8
Total Debt	0.24	0.27	0.14	0.3	0.15	0.32
Net Cash (Debt)	10.81	4.95	6.33	5.79	2	3.75
Net Cash Growth	92.53%	-21.72%	9.16%	189.56%	-46.66%	-
Net Cash Per Share	0.88	0.41	0.53	0.48	0.17	0.31
Filing Date Shares Outstanding	15.35	12	12	12	12	12
Total Common Shares Outstanding	15.35	12	12	12	12	12
Working Capital	12.26	6.31	7.26	9.98	13.23	6.13
Book Value Per Share	0.85	0.59	0.65	0.86	1.13	0.54
Tangible Book Value	13.05	7.03	7.7	10.19	13.45	6.44
Tangible Book Value Per Share	0.85	0.59	0.64	0.85	1.12	0.54

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.

SEC Filings: 10-K · 10-Q